
Conor Stewart
Research expert covering health & pharmaceuticals in the UK & Europe
Get in touch with us nowThe chart is not accessible to screen readers. Please switch to the table view to access the data.
Johnson & Johnson’s medtech (medical devices and diagnostics) segment earned over ****Ìýbillion U.S. dollars through its surgery franchise in 2025. Orthopedics was the second-largest franchise, generating just under ***Ìýbillion U.S. dollars that year.
In 2025, Johnson & Johnson’s global revenue amounted to 94 billion U.S. dollars, which was an increase of around ****billion U.S. dollars compared to 2024. During 2023, the consumer health business of the company was moved in a spin-off. J&J currently has two major segments: Innovative Medicine and Medtech.
In 2025, over ***billion U.S. dollars were generated through the medtech division. That was roughly **Ìýpercent of the company’s total global revenue. Over the years, the multinational company with its various segments generated more than half of its revenues in the United States, making it the company’s main market. In 2025, around ****Ìýbillion U.S. dollars were generated in Europe.
Log in or register to access precise data.
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Company data
In vitro diagnostics
Imaging and screening
AI technology
Market overview
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.